GERN
Price:
$1.15
Market Cap:
$737.75M
Geron Corporation is an advanced-stage biopharmaceutical company dedicated to the creation and market introduction of treatments for myeloid blood cancers. Its primary drug candidate, imetelstat, is a telomerase inhibitor currently undergoing Phase 3 clinical evaluation. This therapy aims to suppress the unchecked proliferation of cancerous stem and progenitor cells characteristic of myeloid hematologic malignancies. Imetelstat is being developed to address low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. Established in 1990, Geron's corporate headquarters are located in Foster City, California.
Industry
Biotechnology
IPO Date
1996-07-31
Stock Exchange
NASDAQ
Ticker
GERN
According to Geron Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 918.81M. This represents a change of -11.91% compared to the average of 1.04B of the last 4 quarters.
The mean historical Enterprise Value of Geron Corporation over the last ten years is 739.27M. The current 918.81M Enterprise Value has changed 12.33% with respect to the historical average. Over the past ten years (40 quarters), GERN's Enterprise Value was at its highest in in the September 2024 quarter at 3.03B. The Enterprise Value was at its lowest in in the December 2018 quarter at 175.50M.
Average
739.27M
Median
435.63M
Minimum
165.66M
Maximum
2.33B
Discovering the peaks and valleys of Geron Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 119.23%
Maximum Annual Enterprise Value = 2.33B
Minimum Annual Increase = -57.47%
Minimum Annual Enterprise Value = 165.66M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.05B | -54.84% |
| 2024 | 2.33B | 90.97% |
| 2023 | 1.22B | 32.54% |
| 2022 | 920.41M | 119.23% |
| 2021 | 419.84M | -7.00% |
| 2020 | 451.42M | 82.37% |
| 2019 | 247.53M | 49.42% |
| 2018 | 165.66M | -38.64% |
| 2017 | 270.00M | -14.60% |
| 2016 | 316.15M | -57.47% |
The current Enterprise Value of Geron Corporation (GERN) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
1.53B
5-year avg
1.19B
10-year avg
739.27M
Geron Corporation’s Enterprise Value is less than Day One Biopharmaceuticals, Inc. (2.03B), greater than Rezolute, Inc. (375.04M), greater than Arvinas, Inc. (410.37M), greater than Valneva SE (537.77M), less than Tyra Biosciences, Inc. (1.53B), less than Vir Biotechnology, Inc. (1.26B), less than Savara Inc. (1.07B), greater than Replimune Group, Inc. (686.64M), greater than LENZ Therapeutics, Inc. (187.73M), less than ArriVent BioPharma, Inc. Common Stock (1.36B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.03B | $2.22B | |
| 375.04M | $385.17M | |
| 410.37M | $489.07M | |
| 537.77M | $507.78M | |
| 1.53B | $1.61B | |
| 1.26B | $1.45B | |
| 1.07B | $1.08B | |
| 686.64M | $733.24M | |
| 187.73M | $212.27M | |
| 1.36B | $1.42B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Geron Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Geron Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Geron Corporation's Enterprise Value?
What is the highest Enterprise Value for Geron Corporation (GERN)?
What is the 3-year average Enterprise Value for Geron Corporation (GERN)?
What is the 5-year average Enterprise Value for Geron Corporation (GERN)?
How does the current Enterprise Value for Geron Corporation (GERN) compare to its historical average?